These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11484873)

  • 21. ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy.
    Almeida S; Fiegenbaum M; de Andrade FM; Osório-Wender MC; Hutz MH
    Maturitas; 2006 May; 54(2):119-26. PubMed ID: 16242874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
    Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
    Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of hormone replacement therapy on weight, abdominal fat distribution, and lipid levels in Japanese postmenopausal women.
    Sumino H; Ichikawa S; Yoshida A; Murakami M; Kanda T; Mizunuma H; Sakamaki T; Kurabayashi M
    Int J Obes Relat Metab Disord; 2003 Sep; 27(9):1044-51. PubMed ID: 12917709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
    Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of estrogen replacement therapy on abdominal fat compartments as related to glucose and lipid metabolism in early postmenopausal women.
    Mattiasson I; Rendell M; Törnquist C; Jeppsson S; Hulthén UL
    Horm Metab Res; 2002 Oct; 34(10):583-8. PubMed ID: 12439787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlations of plasma high-density lipoprotein cholesterol levels with other plasma lipid and lipoprotein concentrations.
    Davis CE; Gordon D; LaRosa J; Wood PD; Halperin M
    Circulation; 1980 Nov; 62(4 Pt 2):IV24-30. PubMed ID: 7188560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
    Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J; Sumino H; Ichikawa S; Ozaki M
    Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid-modifying effects of rosuvastatin in postmenopausal women with hypercholesterolemia who are receiving hormone replacement therapy.
    Shepherd J; Packard C; Littlejohn TW; Walker J; Stein EA; Smith K; Kallend D; Blasetto JW
    Curr Med Res Opin; 2004 Oct; 20(10):1571-8. PubMed ID: 15462690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of E2 and E2/norgestimate hormone therapy on elevated baseline lipids.
    Langer RD; Friedman AJ
    J Reprod Med; 2006 Aug; 51(8):610-6. PubMed ID: 16967629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy.
    Salbach B; Nawroth PP; Kübler W; von Holst Th; Salbach PB
    Eur J Med Res; 2000 Feb; 5(2):63-6. PubMed ID: 10720565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between serum cholesterol and bone mineral density.
    Makovey J; Chen JS; Hayward C; Williams FM; Sambrook PN
    Bone; 2009 Feb; 44(2):208-13. PubMed ID: 18983946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated plasma leptin levels associated with high blood pressure and TG rich lipoproteins but not associated with plasma gonadotropins, estradiol and cortisol levels in peri- and postmenopausal lean women with undefined symptoms.
    Ushiroyama T; Ikeda A; Higashio S; Sakuma K; Ueki M
    J Med; 2004; 35(1-6):63-73. PubMed ID: 18084865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides.
    Nerbrand C; Nyberg P; Nordström L; Samsioe G
    Maturitas; 2002 May; 42(1):55-62. PubMed ID: 12020980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA; Osmanağaoğlu S; Osmanağaoğlu T; Okumuş B; Bozkaya H
    Fertil Steril; 2005 Aug; 84(2):384-93. PubMed ID: 16084879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of antioxidant adjuvant treatment with hormone replacement therapy against cardiovascular diseases in ovariectomized rats.
    Shehata M; Kamel MA
    Endocr Regul; 2008 Jun; 42(2-3):69-75. PubMed ID: 18624609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the metabolic tolerance in postmenopausal women over a 1-year period of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.
    Meuwissen JH; Beijers-De Bie L; Vihtamaki T; Tuimala R; Siseles N; Magaril C; The HS; Houben PW; Murga M; Spielmann D; De Villiers TJ
    Gynecol Endocrinol; 2002 Apr; 16(2):155-62. PubMed ID: 12012627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between plasma viscosity and cholesterol in postmenopausal women on hormone replacement therapy.
    Konukoglu D; Serin O; Ercan M
    Clin Hemorheol Microcirc; 2000; 22(3):223-8. PubMed ID: 10976716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
    Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
    J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.